Financials
| Unaudited Interim Results | Feb. 24, 2025 |
| Final Results | Oct. 21, 2024 |
| Trading Update | Jul. 22, 2024 |
| Half-year Report | Feb. 26, 2024 |
| Audited Preliminary Results | Oct. 16, 2023 |
| Trading update | Jul. 25, 2023 |
| Half-year Report | Feb. 20, 2023 |
Proxies
| Notice of AGM & Posting of Annual Report &Accounts | Nov. 22, 2024 |
| Result of AGM | Dec. 19, 2023 |
| AGM Statement | Dec. 19, 2023 |
| Result of AGM - Replacement | Dec. 14, 2022 |
| Result of AGM | Dec. 12, 2022 |
| AGM Statement | Dec. 12, 2022 |
| Result of AGM | Dec. 13, 2021 |
Ownership Update
| Holding(s) in Company | May. 30, 2025 |
| Director/PDMR Shareholding | Apr. 02, 2025 |
| Holding(s) in Company | Mar. 31, 2025 |
| Director/PDMR Shareholding | Mar. 26, 2025 |
| Holding(s) in Company | Mar. 18, 2025 |
| Director Option Grant | Jan. 23, 2025 |
| Director/PDMR Shareholding | Sep. 20, 2024 |
Announcements
| APIC25 Annual Conference attendance | Jun. 26, 2025 |
| Investor Presentations & Notice of Trading Update | Jun. 02, 2025 |
| Conference attendance at Mello2025 Investor event | May. 28, 2025 |
| Exercise of Share Options and Total Voting Rights | May. 16, 2025 |
| FDA clearance for Tristel OPH | May. 12, 2025 |
| Additional info. submitted to FDA for Tristel OPH | Apr. 10, 2025 |
| Publication of Poster by Mayo Clinic & US update | Apr. 09, 2025 |